TOI’s Stock Swings: Riding the 2025 Wave of Ups and Downs

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded an increase of 556.32%. However, over the last six months, the performance has been weaker by 872.05%. The price of TOI increased 17.67% over the last 30 days. And in the last five days, it has surged by 24.21%.

Oncology Institute Inc (TOI) stock is currently valued at $3.13. During the last session, the stock experienced a remarkable rise, reaching $7.0 after opening at $3.13. The stock briefly dropped to $7.0 before ultimately closing at $2.87.

Oncology Institute Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $3.50 on 04/24/25, while the lowest price for the same duration was marked at $0.13 on 11/21/24.

52-week price history of TOI Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Oncology Institute Inc’s current trading price is -10.57% away from its 52-week high, while its distance from the 52-week low is 2398.00%. The stock’s price range during this period has varied between$0.13 and $3.50. The Oncology Institute Inc’s shares, which operate in the Healthcare, saw a trading volume of around 2.65 million for the day, a figure considerably higher than their average daily volume of 1.88 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Oncology Institute Inc (TOI) has experienced a quarterly rise of 99.36% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 287.69M and boasts a workforce of 825 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.02, with a change in price of +2.17. Similarly, Oncology Institute Inc recorded 1,458,717 in trading volume during the last 100 days, posting a change of +225.67%.

TOI’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for TOI stands at 20.18. Similarly, the long-term debt-to-equity ratio is also 18.83.

TOI Stock Stochastic Average

Oncology Institute Inc’s raw stochastic average for the past 50 days is presently 75.59%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 96.54%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 78.78% and 66.43%, respectively.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.